The TP, ALB, and DBIL levels were lower and the CEA and ALT levels were higher among patients in the HCC group compared to those in the CHB group, and the differences were statistically significant (p < 0.05; Table 1). This evidence concerns the gene CEACAM5 and hepatocellular carcinoma.